Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Syneron Medical Ltd (NASDAQ:ELOS)

9.44
Delayed Data
As of Aug 31
 -0.09 / -0.94%
Today’s Change
8.32
Today|||52-Week Range
12.90
+1.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-51.8M-2.3M1.5M-5.2M
 
 
 
 
 
Depreciation10.0M11.0M10.5M8.3M
 
 
 
 
 
Total Other Cash Flow5.6M6.1M759.0K8.9M
 
 
 
 
 
Funds From Operations-36.2M2.7M9.4M11.0M
 
 
 
 
 
Funds From/For Other Operating Expenses8.5M13.7M31.3M-5.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-44.7M-11.1M-22.0M16.1M
 
 
 
 
 
 
InvestingIncrease In Investments-106.2M-34.3M-58.7M-30.9M
 
 
 
 
 
Decrease In Investments148.6M74.3M56.3M48.9M
 
 
 
 
 
Capital Expenditures-2.1M-2.0M-3.7M-2.8M
 
 
 
 
 
Net Assets From Acquisitions 0.00-15.1M0.00-11.0M
 
 
 
Other Investing - Uses0.00-202.0K-686.0K-9.0K
 
 
 
 
Other Investing - Sources326.0K0.000.000.00
 
 
Net Cash Flow Investing40.7M22.8M-6.8M4.2M
 
 
 
 
 
 
FinancingShort Term Borrowings-1.7M-1.1M0.000.00
 
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale4.1M2.0M7.2M1.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.00-485.0K
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing571.0K7.2M5.2M0.00
 
 
 
 
Net Cash Flow - Financing1.8M-6.3M2.1M1.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash708.0K-1.3M-2.1M-1.7M
 
 
 
 
 
 
Net Change In Cash-2.2M5.3M-26.7M21.3M